Basel Medical is set to acquire up to 10,000 BTC worth about 1 billion USD through issuing shares, reflecting its strategic pivot towards digital assets.
Following the announcement, BMGL shares fell over 8%. However, some investors see the acquisition as a long-term hedge against fiat risks.
This move underscores a growing trend of corporations diversifying into cryptocurrencies as part of their treasury strategies, transcending traditional industry boundaries.
Leave a Reply